Sermorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH 1–29) and is commonly utilized in laboratory and preclinical research examining growth hormone signaling pathways and endocrine communication. Due to its well-defined amino acid sequence, Sermorelin is frequently selected for controlled studies involving peptide-receptor interactions and pulsatile signaling dynamics.
In research environments, Sermorelin has been investigated for its role in stimulating endogenous signaling mechanisms associated with GHRH pathways and downstream cellular communication. Its relatively short half-life and receptor specificity make it a valuable compound for experimental models focused on timing-dependent signaling and regulatory feedback mechanisms.
Each vial is produced under strict quality standards and verified for purity and consistency to support reproducible results in advanced research applications.
Key Research Characteristics
-
Synthetic GHRH (1–29) peptide analog
-
Studied in growth hormone–related signaling pathways
-
Utilized in endocrine and cellular communication research models
-
High-purity formulation for laboratory consistency
Product Specifications
-
Peptide Name: Sermorelin
-
Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂
-
Form: Lyophilized powder
-
Purity: ≥99% (HPLC verified)
-
Storage: Store in a cool, dry environment; refrigerate after reconstitution per research protocol
Important Notice
This product is for research purposes only.
Not for human or animal consumption.
Not intended to diagnose, treat, cure, or prevent any disease.


Reviews
There are no reviews yet.